Drug Profile
UK 447841
Alternative Names: UK-447,841Latest Information Update: 11 Feb 2014
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Neprilysin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Female sexual dysfunction
Most Recent Events
- 01 Jan 2008 Discontinued - Phase-II for Female sexual dysfunction in Sweden (PO)
- 02 Aug 2004 Phase-II clinical trials in Female sexual dysfunction in Sweden (PO)